Short Interest in NEXGEL, Inc. (NASDAQ:NXGLW) Declines By 35.0%

NEXGEL, Inc. (NASDAQ:NXGLW) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 1,300 shares, a decrease of 35.0% from the June 15th total of 2,000 shares. Based on an average daily volume of 1,800 shares, the short-interest ratio is currently 0.7 days.

NEXGEL Stock Performance

Shares of NXGLW remained flat at $0.44 during mid-day trading on Friday. NEXGEL has a 1 year low of $0.11 and a 1 year high of $0.75. The firm’s 50 day simple moving average is $0.43 and its 200 day simple moving average is $0.45.

NEXGEL Company Profile

NEXGEL, Inc manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name.